Pharmaceutical industry puts $44 million into state lobbying

The trade group Pharmaceutical Research and Manufacturers of America (PhRMA) led the lobbying efforts, alone spending more than $4-5 million (Figure 2). Most of the lobbying efforts were directed at blocking the implementation of cost-saving plans, which the group dubbed 'attempts to impose pri...

Full description

Saved in:
Bibliographic Details
Published in:Medical Benefits 2006, Vol.23 (9), p.4
Main Author: Ismail, M. Asif
Format: Newsletterarticle
Language:English
Subjects:
Cost control
Employee benefits
Expenditures
Investments
Laws, regulations and rules
Lobbying
Lobbyists
Management
Medicaid
Pharmaceutical industry
Prescription drugs
State employees
State government
Wage & price controls
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The trade group Pharmaceutical Research and Manufacturers of America (PhRMA) led the lobbying efforts, alone spending more than $4-5 million (Figure 2). Most of the lobbying efforts were directed at blocking the implementation of cost-saving plans, which the group dubbed 'attempts to impose price controls' in its 2003-2004 annual report.
ISSN:0743-8079